Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.

Yuan J, Johnson RL, Huang R, Wichterman J, Jiang H, Hayton K, Fidock DA, Wellems TE, Inglese J, Austin CP, Su XZ.

Nat Chem Biol. 2009 Oct;5(10):765-71. doi: 10.1038/nchembio.215. Epub 2009 Sep 6.

2.

The impact of malaria parasitism: from corpuscles to communities.

Wellems TE, Hayton K, Fairhurst RM.

J Clin Invest. 2009 Sep;119(9):2496-505. doi: 10.1172/JCI38307. Review.

3.

Chloroquine and sulphadoxine-pyrimethamine sensitivity of Plasmodium falciparum parasites in a Brazilian endemic area.

Gama BE, de Oliveira NK, Zalis MG, de Souza JM, Santos F, Daniel-Ribeiro CT, Ferreira-da-Cruz Mde F.

Malar J. 2009 Jul 14;8:156. doi: 10.1186/1475-2875-8-156.

4.

Chloroquine resistance before and after its withdrawal in Kenya.

Mwai L, Ochong E, Abdirahman A, Kiara SM, Ward S, Kokwaro G, Sasi P, Marsh K, Borrmann S, Mackinnon M, Nzila A.

Malar J. 2009 May 18;8:106. doi: 10.1186/1475-2875-8-106.

5.

In vivo and in vitro efficacy of amodiaquine against Plasmodium falciparum in an area of continued use of 4-aminoquinolines in East Africa.

Sasi P, Abdulrahaman A, Mwai L, Muriithi S, Straimer J, Schieck E, Rippert A, Bashraheil M, Salim A, Peshu J, Awuondo K, Lowe B, Pirmohamed M, Winstanley P, Ward S, Nzila A, Borrmann S.

J Infect Dis. 2009 Jun 1;199(11):1575-82. doi: 10.1086/598862.

PMID:
19405863
6.

Analysis of genetic mutations associated with anti-malarial drug resistance in Plasmodium falciparum from the Democratic Republic of East Timor.

de Almeida A, Arez AP, Cravo PV, do Rosário VE.

Malar J. 2009 Apr 9;8:59. doi: 10.1186/1475-2875-8-59.

7.

Aminoalkylphenols as antimalarials (heterocyclicamino)-alpha-amino-o-cresols; the synthesis of camoquin.

BURCKHALTER JH, TENDICK FH, et al.

J Am Chem Soc. 1948 Apr;70(4):1363-73. No abstract available.

PMID:
18915746
8.

Erythrocyte binding protein PfRH5 polymorphisms determine species-specific pathways of Plasmodium falciparum invasion.

Hayton K, Gaur D, Liu A, Takahashi J, Henschen B, Singh S, Lambert L, Furuya T, Bouttenot R, Doll M, Nawaz F, Mu J, Jiang L, Miller LH, Wellems TE.

Cell Host Microbe. 2008 Jul 17;4(1):40-51. doi: 10.1016/j.chom.2008.06.001.

9.

Discordant patterns of genetic variation at two chloroquine resistance loci in worldwide populations of the malaria parasite Plasmodium falciparum.

Mehlotra RK, Mattera G, Bockarie MJ, Maguire JD, Baird JK, Sharma YD, Alifrangis M, Dorsey G, Rosenthal PJ, Fryauff DJ, Kazura JW, Stoneking M, Zimmerman PA.

Antimicrob Agents Chemother. 2008 Jun;52(6):2212-22. doi: 10.1128/AAC.00089-08. Epub 2008 Apr 14.

10.

Association of pfcrt but not pfmdr1 alleles with chloroquine resistance in Iranian isolates of Plasmodium falciparum.

Zakeri S, Afsharpad M, Kazemzadeh T, Mehdizadeh K, Shabani A, Djadid ND.

Am J Trop Med Hyg. 2008 Apr;78(4):633-40.

PMID:
18385361
11.

Short report: polymorphisms in the pfcrt and pfmdr1 genes of Plasmodium falciparum and in vitro susceptibility to amodiaquine and desethylamodiaquine.

Echeverry DF, Holmgren G, Murillo C, Higuita JC, Björkman A, Gil JP, Osorio L.

Am J Trop Med Hyg. 2007 Dec;77(6):1034-8.

PMID:
18165517
12.

Parenteral use of camoquin hydrochloride as an antimalarial.

PAYNE EH, SHARP EA, NICKER KC.

Am J Trop Med Hyg. 1949 May;29(3):353-68. No abstract available.

PMID:
18153039
13.

Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa.

Holmgren G, Hamrin J, Svärd J, Mårtensson A, Gil JP, Björkman A.

Infect Genet Evol. 2007 Sep;7(5):562-9. Epub 2007 Mar 31.

PMID:
17467344
14.

Microsatellite polymorphism within pfcrt provides evidence of continuing evolution of chloroquine-resistant alleles in Papua New Guinea.

DaRe JT, Mehlotra RK, Michon P, Mueller I, Reeder J, Sharma YD, Stoneking M, Zimmerman PA.

Malar J. 2007 Mar 21;6:34.

15.

Return of chloroquine antimalarial efficacy in Malawi.

Laufer MK, Thesing PC, Eddington ND, Masonga R, Dzinjalamala FK, Takala SL, Taylor TE, Plowe CV.

N Engl J Med. 2006 Nov 9;355(19):1959-66.

16.

High reinfection rate and treatment failures in children treated with amodiaquine for falciparum malaria in Muheza villages, Northeastern Tanzania.

Lemnge M, Alifrangis M, Kafuye MY, Segeja MD, Gesase S, Minja D, Massaga JJ, Rønn AM, Bygbjerg IC.

Am J Trop Med Hyg. 2006 Aug;75(2):188-93.

PMID:
16896117
17.

Occurrence of the Southeast Asian/South American SVMNT haplotype of the chloroquine-resistance transporter gene in Plasmodium falciparum in Tanzania.

Alifrangis M, Dalgaard MB, Lusingu JP, Vestergaard LS, Staalsoe T, Jensen AT, Enevold A, Rønn AM, Khalil IF, Warhurst DC, Lemnge MM, Theander TG, Bygbjerg IC.

J Infect Dis. 2006 Jun 15;193(12):1738-41. Epub 2006 May 4.

PMID:
16703518
18.

Quinoline resistance associated polymorphisms in the pfcrt, pfmdr1 and pfmrp genes of Plasmodium falciparum in Iran.

Ursing J, Zakeri S, Gil JP, Björkman A.

Acta Trop. 2006 Mar;97(3):352-6. Epub 2006 Feb 20.

PMID:
16490179
19.

Falciparum malaria in the north of Laos: the occurrence and implications of the Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene haplotype SVMNT.

Dittrich S, Alifrangis M, Stohrer JM, Thongpaseuth V, Vanisaveth V, Phetsouvanh R, Phompida S, Khalil IF, Jelinek T.

Trop Med Int Health. 2005 Dec;10(12):1267-70.

20.

Insight into the early spread of chloroquine-resistant Plasmodium falciparum infections in Papua New Guinea.

Mehlotra RK, Mattera G, Bhatia K, Reeder JC, Stoneking M, Zimmerman PA.

J Infect Dis. 2005 Dec 15;192(12):2174-9. Epub 2005 Nov 11.

PMID:
16288385

Supplemental Content

Support Center